glp-1 receptor agonists benefits Evolution of GLP‐1 for Diabetes Treatment In patients with #obesity, incretin-based
Description
Radeva-Ilieva, M., Stoeva, S., Hvarchanova, N., & Georgiev, K
[DOI] [PMC free article] [PubMed] [Google Scholar] 139
Effect estimates remained robust when restricting to patients with available hemoglobin A1c and including it in the propensity score (Supplementary Table 23)
Effects of Glucagon-Like Peptide-1 receptor agonists on bone health in people living with obesity
Looking ahead, ongoing clinical trials are investigating GLP-1s for an even wider range of conditions, including Alzheimer's disease and alcohol use disorder
